NCT00574860View on ClinicalTrials.gov

EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer

PHASE3TerminatedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Oral MucositisHead and Neck Cancer
Interventions
DRUG

EN3285

Oral rinse

DRUG

Placebo

Oral rinse

OTHER

Standard of care

This will be the therapy most commonly used the the institution treating the patient

Trial Locations (2)

40207

Commonwealth ENT, Louisville

77030

MD Anderson Cancer Center, Houston

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY